Linglin Yang
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 5
- Immunology top 5%
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 4
- Biological Psychiatry top 10%
- Oncology top 10%
- Lung Cancer Research Studies 4
- Molecular Medicine top 10%
-
- Epilepsy research and treatment 6
-
- Angiogenesis and VEGF in Cancer 5
- Cell death mechanisms and regulation 4
-
- Nanoplatforms for cancer theranostics 4
Linglin Yang
55 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Biomaterials 329
- Immunology 500
- Biological Psychiatry 37
- Oncology 394
- Molecular Medicine 61
Countries citing papers authored by Linglin Yang
This map shows the geographic impact of Linglin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linglin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linglin Yang more than expected).
Fields of papers citing papers by Linglin Yang
This network shows the impact of papers produced by Linglin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linglin Yang. The network helps show where Linglin Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linglin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 10 | |
| 5 | 2021 | 30 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 46 | |
| 9 | 2018 | 26 | |
| 10 | 2018 | 6 | |
| 11 | 2018 | 34 | |
| 12 | 2017 | 26 | |
| 13 | 2017 | 6 | |
| 14 | 2016 | 1 | |
| 15 | 2016 | 24 | |
| 16 | 2015 | 17 | |
| 17 | Comparison of Insulin Resistance Indexes of Three Types of Obesity: Phlegm-dampness Constitution,Non Phlegm-dampness Constitution and Metabolic Syndrome | 2014 | 1 |
| 18 | 2013 | 23 | |
| 19 | 2013 | 17 | |
| 20 | 2011 | 15 |
About Linglin Yang
Linglin Yang is a scholar working on Biological Psychiatry, Biomaterials and Cancer Research, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include Epilepsy research and treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Immunotherapy and Immune Responses (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Cell death mechanisms and regulation (4 papers), Nanoplatforms for cancer theranostics (4 papers), Lung Cancer Research Studies (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Biomaterials (329 citations), Immunology (500 citations) and Biological Psychiatry (37 citations). Linglin Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Stephanie K. Bunt, Pratima Sinha, Virginia K. Clements, Jeff Leips, Suzanne Ostrand‐Rosenberg, Shaozhi Fu, Jingbo Wu, Biqiong Wang, Juan Fan and Qinglian Wen. Their work appears in journals such as Oncotarget, Drug Delivery, International Journal of Nanomedicine, European Radiology and Epilepsy & Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.